|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
New findings published in the November 18 issue of the journal Circulation, by scientists at the University of Miami Miller School of Medicine and Duke University, are shedding new light on the biological process involved in the autoimmune disease scleroderma. Researchers hope their new understanding will point the way to prevention and treatment for this dreadful disease. Scleroderma, or systemic sclerosis, is a chronic connective tissue disease in which hardening of the skin is the most visible symptom. The autoimmune disorder, which causes fibrosis or the overproduction of collagen, can sometimes also impact various internal organs, including the lung, heart, kidney and gastrointestinal tract. UM International Medicine Institute Wins International Business Leadership Award
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
The University of Miami International Medicine Institute at the Miller School of Medicine received the Greater Miami Chamber of Commerce’s International Business Leadership Award in the not-for-profit category for its contributions to international medicine, education and research and for its role as a vital component to the South Florida community.
The awards are given annually to companies that engage in international business or activities that support international business development in Florida, and were presented this year at a luncheon held at the Hilton Miami Downtown Hotel on November 20.
|
Cigarette smoking remains the leading preventable cause of death in the United States – accounting for more deaths than HIV, TB, maternal mortality, motor vehicle accidents, suicide and homicide combined. For good reason, seventy percent of adult smokers in the U.S. say they want to quit.
An event hosted today by the UM/Jackson Inpatient Smoking Cessation Consult, a free service launched this year to help patients and others quit smoking, offered tobacco users the tools and inspiration they need to begin the process.
|
D’Zhana Simmons celebrated her 15th birthday over the weekend, just days after being released from Holtz Children’s Hospital at the University of Miami/Jackson Memorial Medical Center, where she was kept alive for 118 days with a custom-made total artificial heart while awaiting a second transplant. She is believed to be the first pediatric patient to survive without a heart while her circulation was supported with the unique device.
“It was really scary being hooked to a machine for four months,” the teenager said softly, in front of a crowd of reporters at a news conference on November 19. Her story made headlines across the United States and around the world.
|
The day media reports announced the Obama Administration intends to tap Tom Daschle, the former South Dakota senator, to become Secretary of Health and Human Services, a former holder of the top government health care post incorporated the news in a lecture to medical students at the Miller School.
In speaking to the students, University of Miami President Donna E. Shalala, who served two terms as HHS Secretary in the Clinton Administration, said Obama’s appointment of Daschle signals “the president-elect is very serious about health care reform.”
|
Shu Wu, M.D., a clinical assistant professor of pediatrics in the Division of Neonatology, who’s conducting research on chronic lung disease in premature infants, was awarded the 2008 Micah Batchelor Award for Excellence in Children’s Health Research on Tuesday evening.
Wu received the award during a ceremony at the Batchelor Children’s Research Institute, before an audience that included UM President Donna E. Shalala, Miller School Dean Pascal J. Goldschmidt, M.D., and Steven Lipshultz, M.D., professor and chair of pediatrics. Also present were board members of the Batchelor Foundation, which makes the award, and the $300,000 prize accompanying it, possible.
|
Implantable cardioverter-defibrillators (ICDs) are medical devices designed to constantly monitor the heart beat, recognize life-threatening heart rhythm disturbances, and deliver a life-saving shock when needed. Patients who have survived a cardiac arrest clearly benefit from these devices.
In addition, certain groups of patients who have survived a myocardial infarction (heart attack) – but have not had a cardiac arrest – can also benefit, but it is difficult to identify the individual patients within those groups who will achieve benefit from an ICD after a heart attack. University of Miami Miller School of Medicine cardiologist Robert Myerburg, M.D., has authored a review article examining and dealing with this problem in the November 20 issue of The New England Journal of Medicine.
|
A paper published by genetic researchers at the Miami Institute for Human Genomics at the Miller School of Medicine received the prestigious Cotterman Award during the annual meeting of the American Society of Human Genetics on November 15. Each year, the editorial board of The American Journal of Human Genetics selects two articles that best represent outstanding contributions to the field of genetics and in which the first author was either a pre or postdoctoral trainee and a member of the American Society of Human Genetics.
Gaofeng Wang, Ph.D., now an assistant professor in the Dr. John T. Macdonald Foundation Department of Human Genetics, served as first author on the paper titled “Variation in the miRNA-433 Binding Site of FGF20 Confers Risk for Parkinson Disease by Overexpression of α-Synuclein” which was published in the February issue of the journal. The FGF20 gene that produces a protein of the same name was previously identified as a risk factor for PD by research teams at the Morris K. Udall Parkinson Disease Research Center of Excellence at the Miller School and the Miami Institute for Human Genomics.
|
Cherie L. Stabler, Ph.D., director of the tissue engineering program at the Diabetes Research Institute at the Miller School, is one of only ten scientists across the country to win the Type 1 Diabetes Pathfinder Award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The award recognizes highly innovative research studies that offer exceptional promise for improving the understanding, prevention and treatment of type 1 diabetes and its complications.
The recipients, all new researchers who have never been principal investigators on an NIH-funded grant, receive about $1.5 million each in direct costs to pursue their work over a five-year period.
|
As associate dean for minority affairs, Astrid K. Mack, Ph.D., was a champion of student diversity at the Miller School and was known for his dedication to steering hundreds of underrepresented minorities to Miller and other medical schools through a long-running health care careers preparatory summer program at the University. For his notable work, the Association of American Medical Colleges (AAMC) on Monday honored Dr. Mack with a Special Recognition Award.
Mack, who retired this summer after 35 years at the Miller School, collected the AAMC’s Group on Student Affairs – Minority Affairs Section (GSA-MAS) special award at the organization’s annual meeting in San Antonio. According to the AAMC, Dr. Mack was recognized for his “unwavering dedication and service to medical students and minority medical students in particular.” The group noted that he “established and sustained a record of commitment and service to minority medical education…and committed to enhancing health care delivery and eliminating health care disparities.”
|
To look at Max S. Eaton, you wouldn’t know that he has survived one heart attack, that he has heart failure -- or that he has made history. Last Thursday, the 66-year-old Broward County man became the first person in the United States to have stem cells injected into his heart using a novel, corkscrew-shaped catheter. Cardiologists at the University of Miami Health System (UHealth) performed the procedure, using bone marrow cell therapy in an effort to treat heart failure.
This trial, the Transendocardial Autologous Cells in Ischemic Heart Failure Trial (TAC-HFT) study, is being led by Joshua M. Hare, M.D., chief of the Cardiovascular Division and director of the Interdisciplinary Stem Cell Institute. It is the world’s first stem cell trial comparing two cell populations, bone marrow cells and mesenchymal cells, against placebo. “This is truly a breakthrough procedure,” says Hare.
|
Over the years, the ALS Recovery Fund has been a steadfast, generous Miller School ally in the fight against amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease.
On Thursday, October 23, the Department of Neurology hosted a reception for the ALS Recovery Fund in the University of Miami Hospital’s Seminar Room. The event was to thank the organization for a $1 million gift partially endowing a chair for Walter G. Bradley, M.D., Miller School professor and chairman emeritus of neurology.
|
Miller School Dean Pascal J. Goldschmidt, M.D., received the Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences during a ceremony at The Ohio State University, in Columbus, Ohio, Monday evening.
Director of cardiology at The Ohio State University College of Medicine and Public Health from 1997 to 2000, Goldschmidt is the inaugural winner of the prize, from The Ohio State University Heart and Vascular Center. The Schottenstein Laureate receives a minimum honorarium of $100,000.
|
The Miami edition of the “Health for Life” community forum, an American Hospital Association event that brings health care and public policy experts and advocates together to discuss needed reforms, opened at the Miller School’s Medical Wellness Center Wednesday with a presentation of statistics depicting the current lack of health care coverage many Floridians face, a dark snapshot of the national landscape where, for many, health care is unaffordable and the system is in crisis.
In Florida, more than 3.7 million people, including more than 541,000 children, make the state the third highest in the country in both the number and percentage of uninsured. In Miami-Dade County alone, 29 percent of residents don’t have health insurance.
Bart Chernow, M.D., vice president for special programs and resource strategy, and vice provost for technology advancement (left at podium), Dean Pascal J. Goldschmidt, M.D., and University President Donna E. Shalala addressed a group of Boston business and civic leaders who visited the Miller School on October 21 as part of its City to City tour of Miami. Through City to City, a Boston leadership development program, participants travel to different cities to learn best practices used to solve a range of economic and social issues. Upon returning to Boston, the team expects to incorporate the best solutions into initiatives to help entities such as schools, non-profits, small businesses, and even neighborhoods, improve social and economic circumstances.
|
Judy Schaechter, M.D., associate professor of pediatrics at the Miller School, received the Clay Hamilton Memorial Hope Award from the Human Services Coalition for her work as an advocate in the struggle to provide healthcare to children and families. The award was presented at “A Prosperity Ball: Celebrating Life’s Riches” hosted by the organization on Saturday, October 11.
“I am very grateful to be named this year’s recipient of the Clay Hamilton Hope Award, but I know that this honor is only possible because I have been so blessed to work with people from the University of Miami, Jackson Memorial, The Children’s Trust, the health department, the schools and the Human Services Council itself, people who believe in our community and have worked together through challenges and obstacles toward a common vision of something better for our children and families,” said Schaechter.
Eduardo C. Alfonso, M.D., interim chairman of the Department of Ophthalmology, and medical director of Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, was named Health Care CEO of the Year by the South Florida Business Journal .
After more than 25 years of distinguished service as professor and chairman of the Department of Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine, James D. Potter, Ph.D., has decided to step down as chairman to pursue his research full time.
Dean Goldschmidt outlines progress on strategic plan and his vision for the future of the Miller School and UHealth at a town hall meeting Despite a global financial crisis and a weakened economy, Dean Pascal J. Goldschmidt, M.D., is moving ahead with the strategic plan he introduced soon after joining the Miller School -- a plan that all employees of the School, faculty, staff and students, were asked to help design.
|
Copyright © 1997-2007 University of Miami, All Rights Reserved. |
Terms of Use Privacy Statement Contact Us |
Medical Disclaimer Site Map Web Technology |